BioRestorative Therapies (BRTX) Other Gross PP&E Adjustments (2017 - 2024)
Historic Other Gross PP&E Adjustments for BioRestorative Therapies (BRTX) over the last 12 years, with Q4 2024 value amounting to -$7.2 million.
- BioRestorative Therapies' Other Gross PP&E Adjustments rose 5044.44% to -$7.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$7.2 million, marking a year-over-year increase of 5044.44%. This contributed to the annual value of -$7.2 million for FY2024, which is 5044.44% up from last year.
- Per BioRestorative Therapies' latest filing, its Other Gross PP&E Adjustments stood at -$7.2 million for Q4 2024, which was up 5044.44% from -$39697.0 recorded in Q3 2024.
- In the past 5 years, BioRestorative Therapies' Other Gross PP&E Adjustments ranged from a high of -$39697.0 in Q3 2024 and a low of -$14.6 million during Q4 2023
- Its 5-year average for Other Gross PP&E Adjustments is -$2.6 million, with a median of -$401321.5 in 2021.
- As far as peak fluctuations go, BioRestorative Therapies' Other Gross PP&E Adjustments crashed by 17247.72% in 2021, and later skyrocketed by 7434.37% in 2024.
- BioRestorative Therapies' Other Gross PP&E Adjustments (Quarter) stood at -$3.6 million in 2020, then plummeted by 172.48% to -$9.9 million in 2021, then fell by 29.51% to -$12.9 million in 2022, then fell by 13.35% to -$14.6 million in 2023, then skyrocketed by 50.44% to -$7.2 million in 2024.
- Its last three reported values are -$7.2 million in Q4 2024, -$39697.0 for Q3 2024, and -$78146.0 during Q2 2024.